Beak and feather disease virus in wild and captive parrots: an analysis of geographic and taxonomic distribution and methodological trends by unknown
REVIEW
Beak and feather disease virus in wild and captive parrots:
an analysis of geographic and taxonomic distribution
and methodological trends
Deborah J. Fogell1 • Rowan O. Martin2,3 • Jim J. Groombridge1
Received: 9 January 2016 / Accepted: 24 April 2016 / Published online: 5 May 2016
 The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract Psittacine beak and feather disease (PBFD) has
emerged in recent years as a major threat to wild parrot
populations and is an increasing concern to aviculturists
and managers of captive populations. Pathological and
serological tests for screening for the presence of beak and
feather disease virus (BFDV) are a critical component of
efforts to manage the disease and of epidemiological
studies. Since the disease was first reported in the mid-
1970s, screening for BFDV has been conducted in
numerous wild and captive populations. However, at pre-
sent, there is no current and readily accessible synthesis of
screening efforts and their results. Here, we consolidate
information collected from 83 PBFD- and BFDV-based
publications on the primary screening methods being used
and identify important knowledge gaps regarding potential
global disease hotspots. We present trends in research
intensity in this field and critically discuss advances in
screening techniques and their applications to both avi-
culture and to the management of threatened wild popu-
lations. Finally, we provide an overview of estimates of
BFDV prevalence in captive and wild flocks alongside a
complete list of all psittacine species in which the virus has
been confirmed. Our evaluation highlights the need for
standardised diagnostic tests and more emphasis on studies
of wild populations, particularly in view of the intrinsic
connection between global trade in companion birds and
the spread of novel BFDV strains into wild populations.
Increased emphasis should be placed on the screening of
captive and wild parrot populations within their countries
of origin across the Americas, Africa and Asia.
Introduction
Pathogens responsible for emerging infectious diseases
(EIDs) have become a major concern in conservation
biology owing to their potential for rapid evolution and the
effect that an epidemic may have on vulnerable species [1].
Consequently, understanding infectious diseases and their
management in wildlife populations has become increas-
ingly important to conservationists [2]. Assessing the
prevalence and impact of disease can be challenging, par-
ticularly during the outbreak of a novel pathogen [3]. Data
collected and used in these circumstances often vary in the
sampling or assessment method used, frequently with
imperfect diagnostic tests providing the only available
insight into infection incidence within a population [4, 5].
Consequently, synthesising multiple sources of information
across many species can provide insight into how to
improve management of infectious disease, identify
knowledge gaps, and reveal where improvements in
surveillance methods might be required.
Psittacine beak and feather disease (PBFD) has been
detected in both wild and captive parrot populations since
the mid-1970s. The disease has been found to be widely
infectious and often fatal, affecting both Old and New
World psittacine species. PBFD is thought to have been
first documented in the late 1880s in wild Australian
Psephotus parrots and was described as feathering
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abnormalities that impaired their flight [6]. Most com-
monly affecting immature and fledgling birds, classical
symptoms include symmetrical loss of contour, tail and
down feathers and subsequent replacement by dystrophic
and necrotic feathers that fail to grow soon after emergence
from the follicle [7–9]. Beak deformities such as fractures,
abnormal elongation and palatine necrosis are also typical
symptoms of PBFD, but their presence and severity vary
from species to species [10]. Other clinical symptoms
include lethargy, depression, diarrhoea and immunosup-
pression, which are individually variable, sometimes lead
to death, and may depend on the virulence of the viral
strain or the route of viral exposure [11].
Beak and feather disease virus (BFDV) is a member of
the family Circoviridae [12], which includes the smallest
known autonomously replicating pathogenic animal viruses
[13–15]. The first complete BFDV genome sequence con-
firmed its relationship to other circoviruses [16]. The
structure of BFDV isolated from viral inclusion bodies was
determined to be a non-enveloped, icosahedral virion
between 14 and 16 nm in size and containing a single-
stranded DNA genome approximately 1.7 to 2.0 kilobases
in length [10].
Until the early 1990s, histology and recovery of virions
were the primary means of determining whether a bird was
infected with BFDV. The first haemagglutination (HA) and
haemagglutination inhibition (HI) assays were then devel-
oped as a technique for both the identification and quan-
tification of virus recovered from BFDV-positive birds
[17]. Since the initial description of the syndrome, several
attempts have been made to culture the virus in vitro in
order to provide a source of antigen for vaccinations, but
these have not yet been successful [16, 18, 19]. The lack of
an effective vaccine has compelled researchers to develop
techniques to further examine the molecular genetics of the
virus; encouraging development of oligonucleotide-probe-
based methodologies such as dot-blot DNA hybridization,
DNA in situ hybridization, and a polymerase chain reaction
(PCR)-based assay [20, 21]. Critically, as infection and the
presentation of clinical disease are fundamentally different
[22], these techniques provided a means to determine
whether infection was present, even when the individual
being studied was asymptomatic. The small size of cir-
coviruses means that whole-genome sequencing is rela-
tively quick and inexpensive, facilitating investigations of
phylogenetic relationships between different viruses within
the family and between strains of the same virus occurring
in different hosts or global regions [23–25].
PBFD has become a major cause for concern to con-
servationists and aviculturists as the disease has spread
rapidly across the world due to BFDV’s high environ-
mental persistence and ability to shift between closely
related host species [26–28]. BFDV is readily transmitted
through contact with contaminated feather dust, surfaces or
objects [29], and it can also be passed directly from a
female to her offspring [10, 30]. The management of PBFD
in captivity is economically important in some countries;
for example, it was estimated that aviculturists in South
Africa lose up to 20 % of their flock to the disease annually
[31]. Worryingly, many wild populations of vulnerable
species are also affected, including the Cape parrot (Poi-
cephalus robustus) of South Africa [25], the Australian
orange-bellied parrot (Neophema chrysogaster) [28, 32]
and swift parrot (Lathamus discolor) [33], and the Mauri-
tius (or ‘‘echo’’) parakeet (Psittacula echo) [30]. Therefore,
understanding the mechanics behind the spread of BFDV
and how to test for its prevalence has taken on a renewed
global relevance.
Concern over the implications for conservation, avicul-
ture and biosecurity together with methodological advan-
ces in the detection of the virus has prompted a recent
increase in research effort. The development of new
methodologies has provided the basis on which researchers
are now able to model the potential routes of transmission
around the world [34], link BFDV prevalence to manage-
ment-related tools for endangered species recovery [35],
and determine the ways in which anthropogenic activities
have changed the way in which the virus is evolving due to
recombination [36]. Remarkably, whilst there are many
research teams worldwide working on BFDV and PBFD,
there is a severe lack of synthesised knowledge on the
primary screening methods being used, the species affec-
ted, and, consequently, potential disease hotspots that have
lacked attention. Here, we aim to consolidate the most
pertinent patterns and methods emerging from the literature
published since the first scientific description of PBFD in
1984 to provide both a qualitative and quantitative over-
view of approaches and screening results. Our review
provides a much-needed source of information for use by
conservation practitioners regarding BFDV prevalence
estimates in captive and wild flocks. Our objective is not to
provide an exhaustive description of each technique, but
instead to analyse the trends in how screening has pro-
gressed over the last three decades and provide an over-
view of prevalence estimates for this infectious disease




Searches for literature were conducted by entering English
key words and terms into Google Scholar and were
selected to balance search sensitivity with specificity. The
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terms were ‘‘Beak and feather disease virus’’, ‘‘Psittacine
beak and feather disease’’, ‘‘Beak and feather disease’’,
‘‘Psittacine circovirus’’, ‘‘BFDV screening’’, ‘‘PBFD
screening’’, ‘‘BFDV detection’’ and ‘‘PBFD detection’’.
Acquisition of literature was restricted to only those arti-
cles that had been published in academic journals or as
conference proceedings up to and including July 2015, thus
excluding any theses and organisational reports.
Analysis
Information extracted from each publication included the
year published, whether the birds studied originated in the
wild or in captivity, the host species, the country of origin
of all specimens, tissue types and laboratory methods used
in the detection of BFDV, and the outcome of diagnostic
tests, including detection prevalence. If an estimate of total
population prevalence was provided, this value was also
recorded.
The publications were grouped into five-year intervals to
examine the trend in the number of publications produced
over time. If multiple species from the same country of
origin were involved in the same study, the country of
origin was recorded once per publication. If the study was
based on captive individuals and a different country of
origin for a specimen was not otherwise clearly stated in
the publication, it was assumed that the country in which
the study was undertaken was the country of origin. In
multiple instances, the countries in which the tests were
conducted differed from the country of origin of the par-
rots. In such instances, it is not possible to determine if the
parrots were infected with the virus in the country of origin
or upon arrival at their destination. Thus, the presence of
the virus in a parrot originating from a given country does
not necessarily indicate its presence in wild or captive
populations in the country of origin. Where a study used
specimens from both captive and wild individuals from the
same country, the country of origin for each specimen was
recorded once per category for each publication. For
example: Regnard et al. [37] screened specimens from both
captive and wild populations of Poicephalus robustus, and
this information was recorded by adding South Africa once
to each category. Maps were produced using ArcGIS
10.2.1 [38], displaying the results of captive and wild
specimens independently. Seven publications did not
declare whether the specimens obtained were of wild or
captive origin. These reports pertained to five incidences
from Australia, one from the United States of America
(USA) and one from Brazil. These incidences were all
excluded from the analyses of geographical patterns. The
common names of species historically recorded as positive
for PBFD/BFDV were aligned to current nomenclature as
per the International Union for Conservation of Nature
(IUCN) Red List database, alongside additional informa-
tion regarding their current IUCN status and native geo-
graphic region.
Screening methods were recorded once per publication.
The annual trends in the five most frequently used
screening methods were assessed, along with the overall
most commonly combined mixed-methods approaches. As
with country of origin, tissues used for screening and
diagnostics were divided into wild and captive specimens,
and, where a study used a certain tissue type from both
captive and wild individuals, that type was recorded once
per category for each publication.
Results
Publication trends and affected species
There has been a linear increase in the number of publi-
cations involving testing for BFDV since the first scientific
description of PBFD (Fig. 1, R2 = 0.96), with the total
number of screening-based publications reaching 83 by
July 2015. The total number of publications on BFDV
screening and prevalence is by far the highest for the most
recent period (between 2011 and July 2015), being 33.3 %
higher than the number of publications for the five-year
period preceding it and more than 300 % higher than the
first full 5-year period from 1986-1990.
Research has been focused predominantly on captive
populations, encompassing 33 different countries, with the
highest number of specimens originating from the USA,
followed by South Africa, Australia and Japan (Fig. 2). In
contrast, relatively few published studies exist for wild
Fig. 1 The number of publications in academic journals reporting the
presence of PBFD or results of BFDV screening produced between
1984 and July 2015
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populations, including only eight nations. Of these studies,
a substantial proportion (12 of 38) were on specimens of
Australian origin. There have been no published studies of
wild parrots in the New World or continental Asia. Three
of these 38 studies were based on screening for BFDV
among exotic introduced populations of non-native species
from the United Kingdom [39], Mauritius [30] and New
Zealand [40]. BFDV was reported to be present in all
countries for which the results of screening of wild or
captive populations have been published, with the excep-
tion of Senegal.
Of the 78 species in which BFDV has been detected in
wild or captive birds (Table 1) 64.1 % (50 species) are
categorised as Least Concern by the IUCN [41], 9.0 % are
considered to be Near Threatened, and over a quarter are
classified in Threatened categories. A declining population
was observed in over 60 % of BFDV-affected host species.
Of the 20 species in which BFDV has been detected among
wild populations, 70.0 % (n = 14) are currently cate-
gorised as Least Concern, two are classified as Near
Threatened, and the remaining four are classified in
Threatened categories. Half (n = 10) were determined to
have host populations increasing in population size [41]. In
addition, wild populations of three subspecies have also
tested positive for BFDV, all of which are native to the
Oceania region.
The summarised captive and wild population BFDV
prevalence estimates are reported in Table 2. Prevalence
estimates have been provided for nine national captive
populations globally, comprising four from Europe (two of
which were for Poland), two from Oceania, two from East
Asia and one from Central America. These estimates vary
in their scope, from describing prevalence in a subset of
species (e.g., parakeets, [42]) to estimating BFDV
Fig. 2 The geographical distribution of research into BFDV and
PBFD in captive and wild parrots during the period 1984-July 2015.
Countries are coloured according to the number of published studies
involving specimens originating from that country. BFDV has been
confirmed to occur in all countries from which the results of screening
have been published, with the exception of Senegal. The United
Kingdom is the only country in which no native parrots occur but
BFDV has been detected in wild invasive flocks
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Table 1 Psittacine species in which BFDV has been detected through diagnostic tests. Species for which wild populations have tested positive
are marked with an asterisk (*)








Amazona aestiva LC Decreasing South America [78, 79]
White-fronted Amazon Amazona albifrons LC Increasing North and Central America [59, 80]
Orange-winged
Amazon
Amazona amazonica LC Decreasing South America [36]
Yellow-naped Amazon Amazona auropalliata VU Decreasing Central and South America [20, 59]
Red-lored Amazon Amazona autumnalis LC Decreasing North, Central and South America [21, 75]
Vinaceous-breasted
Amazon
Amazona vinacea EN Decreasing South America [80]
Blue-and-yellow
macaw
Ara ararauna LC Decreasing South America [80]
Red-and-green macaw Ara chloropterus LC Decreasing South America [20]
Scarlet macaw Ara macao LC Decreasing South and Central America [31, 81]
Military macaw Ara militaris VU Decreasing North and South America [79]
Red-fronted macaw Ara rubrogenys EN Decreasing South America [80]
Sun parakeet Aratinga solstitialis EN Decreasing South America [79]
Pacific parrotlet Forpus coelestis LC Stable South America [36]
Golden parakeet Guarouba guarouba VU Decreasing South America [80]
Green-thighed parrot Pionites leucogaster EN Decreasing South America [31, 65]
Black-headed parrot Pionites melanocephalus LC Stable South America [20]
Bronze-winged parrot Pionus chalcopterus LC Decreasing South America [80]
Crimson-fronted
parakeet
Psittacara finschi LC Increasing Central America [59]
Old World
Nyasa lovebird Agapornis lilianae NT Decreasing East Africa [82, 83]
Black-cheeked lovebird Agapornis nigrigenis* VU Decreasing East Africa [61, 83]
Peach-faced lovebird Agapornis roseicollis LC Decreasing Southern and Central Africa [48, 84]
Australian king parrot Alisterus scapularis LC Decreasing Oceania [36]
Red-winged parrot Aprosmictus erythropterus LC Increasing Oceania and South East Asia [36]
Australian ringneck Barnardius zonarius (barnardi)* LC Increasing Oceania [85, 86]
White cockatoo Cacatua alba EN Decreasing South East Asia [87, 88]
Solomon’s corella Cacatua ducorpsii LC Stable Oceania [21, 80]
Sulphur-crested
cockatoo
Cacatua galerita* LC Decreasing Oceania and South East Asia [45, 89]
Triton cockatoo Cacatua galerita triton Not assessed Oceania [20, 87]
Tanimbar corella Cacatua goffiniana NT Decreasing South East Asia [87, 90]
Philippine cockatoo Cacatua haematuropygia CE Decreasing South East Asia [17, 90]
Major Mitchell’s
cockatoo
Cacatua leadbeateri LC Stable Oceania [76, 84]
Moluccan cockatoo Cacatua moluccensis VU Decreasing South East Asia [79, 91]
Blue-eyed cockatoo Cacatua ophthalmica VU Decreasing Oceania [80]
Bare-eyed corella Cacatua sanguinea* LC Increasing Oceania and South East Asia [92]
Yellow-crested
cockatoo
Cacatua sulphurea CE Decreasing South East Asia [51, 91]
Citron-crested cockatoo Cacatua sulphurea citrinocristata Not assessed South East Asia [17, 51]
Eastern long-billed
corella
Cacatua tenuirostris* LC Increasing Oceania [84, 92]
Gang gang cockatoo Callocephalon fimbriatum* LC Increasing Oceania [26, 93]
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Table 1 continued







Calyptorhynchus banksii* LC Decreasing Oceania [93]
Glossy black cockatoo Calyptorhynchus lathami LC Decreasing Oceania [93]
Vasa parrot Coracopsis vasa LC Stable East Africa [79, 94]
Yellow-fronted
parakeet
Cyanoramphus auriceps* NT Decreasing Oceania [46]
Red-fronted parakeet Cyanoramphus novaezelandiae
(saisseti)*
NT Decreasing Oceania [52, 73]
Antipodes parakeet Cyanoramphus unicolor VU Stable Oceania [42]
Eclectus parrot Eclectus roratus LC Decreasing Oceania and South East Asia [20, 95]
Galah Eolophus roseicapilla* LC Increasing Oceania [84, 92]
Red lory Eos bornea* LC Decreasing South East Asia [96]
Horned parakeet Eunymphicus cornutus VU Increasing Oceania [97]
Musk lorikeet Glossopsitta concinna LC Stable Oceania [65]
Purple-crowned
lorikeet
Glossopsitta porphyrocephala LC Decreasing Oceania [66]
Swift parrot Lathamus discolor* EN Decreasing Oceania [33, 76]
Budgerigar Melopsittacus undulatus LC Increasing Oceania [98, 99]
Orange-bellied parrot Neophema chrysogaster* CE Decreasing Oceania [28, 100]
Kea Nestor notabilis VU Decreasing Oceania [80]
Bluebonnet Northiella haematogaster LC Decreasing Oceania [48, 84]
Cockatiel Nymphicus hollandicus LC Stable Oceania [57, 101]
Crimson rosella Platycercus elegans* LC Decreasing Oceania [36, 54]
Adelaide rosella Platycercus elegans adelaidae* Not assessed Oceania [54]
Yellow rosella Platycercus elegans flaveoulus* Not assessed Oceania [54]
Eastern rosella Platycercus eximius* LC Increasing Oceania [45, 52]
Brown-headed parrot Poicephalus cryptoxanthus LC Stable Southern and East Africa [102,
103]
Red-fronted parrot Poicephalus gulielmi LC Decreasing West, Central and East Africa [104,
105]
Cape parrot Poicephalus robustus* LC Decreasing West, Central, East and Southern
Africa
[25, 80]
Ru¨ppell’s parrot Poicephalus rueppellii LC Decreasing Southern and Central Africa [31, 104]
Red-bellied parrot Poicephalus rufiventris LC Stable East Africa [31, 104]
Senegal parrot Poicephalus senegalus LC Stable West Africa [79, 104]
Regent parrot Polytelis anthopeplus* LC Decreasing Oceania [80, 106]
Palm cockatoo Probosciger aterrimus LC Decreasing Oceania and South East Asia [9, 75]
Red-rumped parrot Psephotus haematonotus LC Increasing Oceania [95]
Red-breasted parakeet Psittacula alexandri NT Decreasing South East and South Central Asia [80]
Echo parakeet Psittacula echo* EN Increasing East Africa [30]
Alexandrine parakeet Psittacula eupatria NT Decreasing South East and South Central Asia [36, 58]
Rose-ringed parakeet Psittacula krameri* LC Increasing West, Central, East Africa; South
Central Asia
[39, 107]
Edwards’ fig-parrot Psittaculirostris edwardsii LC Stable Oceania [80]
African grey parrot Psittacus erithacus VU Decreasing West, Central and East Africa [19, 108]
Timneh parrot Psittacus timneh VU Decreasing West Africa [20, 58]
Scaly-breasted lorikeet Trichoglossus chlorolepidotus LC Stable Oceania [80]
Olive-headed lorikeet Trichoglossus euteles LC Stable South East Asia [80]
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prevalence across entire national captive populations (e.g.
[43]). Among wild populations, seven of eight publications
reporting prevalence estimates are from the Oceania
region, with four from New Zealand alone. Cacatua
galerita populations in Australia were estimated to have a
viral prevalence of between 10 and 20 % [44], slightly
below the minimum estimate provided for populations in
New Zealand two decades later [45]. The lower limits of
the 95 % confidence interval surrounding BFDV preva-
lence in wild Platycercus eximius populations in New
Zealand provided by two separate research groups, five
years apart, are comparable [45, 46]. However, the upper
limit varies from 20.4 % to more than double, at 42.3 %.
Similarly, the two estimates for Cyanoramphus novaeza-
landiae populations differ greatly from one another [46,
47], with the upper limit of the 2012 estimate
Table 1 continued







Trichoglossus forsteni NT Decreasing South East Asia [80]





Not assessed Oceania [95]
Red-collared lorikeet Trichoglossus rubritorquis LC Decreasing Oceania [29, 65]
Yellow-tailed black-
cockatoo
Zanda funerea LC Stable Oceania [109]




Test prevalence Methods used Reference
Captive
Germany 39.2 % from 32 captive breeding facilities PCR [110]
Australia 23 % (PCR)/66.7 % (HA) of samples submitted by veterinarians PCR, HA, HI [65]
Italy 8.05 % for entire national captive population PCR [43]
Taiwan 41.2 % of birds submitted by private owners PCR [111]
New Zealand \7 % cumulative parakeet species PCR, Histology [42]
Poland 25.3 % for entire national captive population; 22.12 % - small aviaries; 25.23 % - medium
aviaries; 25.99 % - large aviaries
PCR [112]
Costa Rica 19.7 % for entire national captive population PCR [59]
Japan 31.3 % of imported birds for breeding PCR [58]




Australia Cacatua galerita - 10 - 20 % (200 - 1000 individuals) over 4 years Histology [44]
New Zealand Platycercus eximius - 8.6-20.4 %, Cacatua galerita - 22-33 % PCR, Histology [45]
New Zealand 4–7 % across all native species PCR, Histology [42]
New Zealand Cyanoramphus novaezalandiae - 28 % PCR [47]
New Zealand Cyanoramphus novaezalandiae - 10.5 % (95 % CI: 6.1 %–16.4 %); Cyanoramphus





Mauritius Psittacula echo - 2004/05 - 38 %; 2005/06 - 41 %; 2006/07 - 11 %; 2007/08 - 25 %;




Trichoglossus haematodus deplanchii - 25 % (11-45 %) PCR, Whole-genome
sequencing
[40]
Australia Platycercus elegans - 45-50 %; Platycercus elegans adelaidae - 95-100 %; Platycercus
elegans flaveoulus - 18-22 %, WS hybrids - 8-10 %
qPCR, HI [54]
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approximately 12 % lower than the total estimate provided
in 2009. The only estimates for African populations are
from Mauritius, where the endemic parakeet population
was screened annually throughout the duration of the study.
From 2004 to 2009, the estimated total prevalence varied
from 11 to 41 % [30].
Most frequently used laboratory methods
Of the 83 publications evaluated, 48.2 % (n = 40) of them
used a single method for detecting BFDV, with standard
PCR-based assays being the most frequently applied
(42.5 %), followed by whole-genome sequencing (27.5 %)
and histology (17.5 %), respectively.
Histology using both light and scanning electron
microscopy has been one of the most frequently and con-
sistently used methods from 1984 to present. Of the 14
methods available for screening and diagnostics, histology
has been used at least once in combination with all but
quantitative (or real-time) polymerase chain reaction
(qPCR), blocking ELISA and duplex shuttle PCR. An
ELISA test was first developed for screening in the mid-
1980s [18], but no BFDV screening-based publications
used this method until more than two decades later
(Table 3), after which it was never used again. Similarly,
the duplex shuttle PCR method has been used only once.
Both HA and HI were used on 12 occasions since their first
application in 1991 (Table 3). However, HA was not used
at all in the most recent (2011 to July 2015) publication
period (Fig. 3).
The standard PCR-based assay has been the most fre-
quently used screening method, applied in 49.4 % of
reported studies between 1984 and July 2015 (Table 3).
The method was initially applied in only two of 11 studies
published in the period 1991-1995 but was consistently the
most used between 1996 and 2010. Of the 35 publications
that used standard PCR from 2000 onwards, 24 used the
protocol and/or oligonucleotide primers developed by
Ypelaar et al. [48]. The application of both PCR and
whole-genome sequencing is considerably higher than any
other mixed-method approach. These were used together in
12 studies, in nine of which they were the only methods
used. In the period from 2011 to July 2015, applications of
whole-genome sequencing exceeded those of standard PCR
for BFDV screening (Fig. 3) and were used in 52.3 % of
publications since its first application in 2004. Rolling-
circle amplification using Phi29 DNA polymerase [49] was
first used for whole-genome sequencing of BFDV in 2005
and has been applied in 47.8 % of studies using this
technique. Subsequently, the methods as described by
Shepherd et al. [50] have been applied across all studies
using Phi29 DNA polymerase for BFDV whole-genome
amplification since its publication.
Tissue types used for screening
A total of 13 tissue types have been used for BFDV
screening since 1984: beak, blood, bone marrow, cloacal
swabs, crop samples, embryonated and non-embryonated
eggs, faeces, feather dust, feathers, muscle tissue, skin and
viscera. All tissue types, aside from beak, have been used
for screening on at least one occasion in captive popula-
tions, with feathers used the most frequently (34.2 %),
followed by blood (32.5 %) and viscera (13.7 %). Con-
versely, only six tissue types have been used in the
screening of wild populations. As with captive populations,
blood (41.2 %) and feathers (37.3 %) were the most
commonly used source for samples, with viscera studied
9.8 % of the time and beak used on only one occasion.
Descriptions of clinical signs
Basic visual body condition assessments were mentioned in
36 of the 83 publications and ranged from a brief statement
of the presence or absence of feather disorder [20, 51] to
more in-depth observations regarding overall body condi-
tion [39, 52]. More-thorough scoring systems for the
classification of clinical symptoms were applied in eight
studies. The most descriptive of these systems was by
Regnard et al. [37], consisting of six different clinical
symptoms, with each broken down into five different
scores of overall physical condition, and these scores were
then compared to individual viral load. Other scales, such
as that applied by Ritchie et al. [9, 17], descriptively scored
only clinical feather and beak lesions.
Field methods used to obtain wild specimens
Only 16 of the 38 studies reporting BFDV incidence in
wild birds discussed the field methods used to obtain their
specimens. The most frequently used method was mist
netting, reported in 11 of the 16 publications (e.g. [37, 40,
46]). The second most preferred method was trapping,
either whilst individuals were in nests [44, 53] or with
walk-in traps [53, 54]. Other studies were undertaken on
specimens gathered opportunistically from mortality cases
and individuals brought in for health checks [42].
Discussion
Patterns in global PBFD and BFDV research
Interest in the screening for, spread and impact of BFDV
and PBFD globally has steadily increased over the last
three decades, with a particular focus on wild populations
in the last five years. Over the course of this period, the
2066 D. J. Fogell et al.
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focus in research has shifted from basic descriptions of
patterns of presence or prevalence in populations towards
studies investigating the processes of viral recombination,
evolution and phylogenetics (e.g. [36, 55]), the causes of
outbreaks in wild populations (e.g. [28, 40]), and the
implications for improving the management of captive and
wild populations. However, despite the burgeoning interest
in assessing incidence in wild populations, some conspic-
uous research gaps are apparent, which future research
should aim to fill. Oceania is undoubtedly the geographical
region that has received the most research attention
regarding the incidence of BFDV in both wild and captive
populations. This geographical bias may partly be due to
evolutionary studies suggesting the virus likely originated
from this region, as well as the recognition of PBFD as a
disease of concern to the recovery of endemic parrot
populations there and a key threat to biodiversity [32, 56].
In contrast, there has been very little published research on
BFDV in proximate geographical regions of high parrot
diversity such as Southeast and Southern Asia.
Table 3 A summary of all methods used in screening for BFDV in wild and captive psittacine populations, a count of how many published





Blocking ELISA A blocking ELISA is a method used to immobilize biomolecules, primarily proteins, to a plate
via passive or covalent interactions, minimising nonspecific binding to the surface by




DNA in situ hybridization is a technique used in the localisation of specific nucleic acid





Dot blot hybridization is a technique used to determine the abundance of certain DNA in an
extraction dotted onto a membrane through hybridization with universal and specific
oligonucleotide probes
2 [20, 21]
Duplex shuttle PCR Duplex shuttle PCR is a process that allows the co-amplification of separate regions of a gene




Endocrinological response is a method used to challenge the host immune system with a
hormone that encourages the production and release of a stress hormone to evaluate whether




Haemagglutination assay (HA) is a method used to quantify the amount of virus attached to




A modified version of the HA where a standard amount of virus and host blood cells are used
with the addition of a serially diluted antiserum to determine which concentration inhibits
agglutination of the cells
12 [9, 65]
Haematology Haematology is the study of the morphology and physiology of blood and, in this context,
relates to the diagnosis and monitoring of pathogens present in the blood stream
3 [87, 89]
Histology Histology is the microscopic examination of stained tissues and is applied in the screening for





Immunohistochemistry (IHC) is a technique used to observe the physical characteristics of
antibodies and their concentration and distribution within host tissue. In screening for
BFDV, specimens are stained using the avidin-biotin complex (ABC) immunoperoxidase




Quantitative (or real-time) polymerase chain reaction (qPCR) is a technique used to both
amplify and quantify target DNA through the use of either nonspecific fluorescent dyes that
intercalate with double-stranded DNA or a sequence-specific fluorescent probe that
hybridizes with the target
6 [37, 54]
Standard PCR Polymerase chain reaction (PCR) is a technology used to amplify a piece of DNA across
several orders of magnitude through a process of thermal cycling in combination with
oligonucleotide probes synthesised to bind to the target region and a DNA polymerase
enzyme
41 [48, 102]
Virus purification Virus purification allows the careful study of viral synthesis within cells by combining
ultracentrifugation, adsorption chromatography, electrophoresis, and partition in liquid




Whole-genome sequencing is a laboratory process that determines the complete DNA
sequence of an organism’s genome at a single time and can be used for multiple tissue types
and when only very small quantities of a full DNA copy are present
23 [115, 116]
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This bias in research attention to some extent likely
reflects publication bias against negative results. The
authors are aware of several screening studies in which the
virus was not detected but the results of these studies have
not been published and hence have not been included in
this review. There is a need to make the results of such
screening initiatives publicly available for further scrutiny,
especially in light of the evidence that some species, such
as cockatiels (Nymphicus hollandicus), may be less sus-
ceptible to BFDV infection [57]. Many aviculturists rou-
tinely test translocated birds for BFDV, but there is little
incentive to publish the results of such tests; indeed, there
may even be disincentives to publish positive results
among commercial breeders. Approaches to gathering test
results that preserve anonymity may improve the avail-
ability of data.
Given that Cacatua was the genus from which PBFD
was first described, 11 species of which have proven to be
susceptible to BFDV infection, to date, there has been very
little research on BFDV/PBFD in areas of Southeast Asia
to which many of these species are native. The virus has
been found in specimens from both wild and captive
populations in Indonesia, a country that contains many
psittacine breeding farms [58] and is heavily exploited for
both the legal and illegal trapping and export of companion
birds for the pet trade [41]. Equally, with high levels of
parrot endemicity in South and Central America, it is
surprising that no studies have been published on BFDV or
PBFD incidence in wild populations. Only two studies
have been conducted on captive individuals originating
from these geographical regions: one from Costa Rica [59]
and another that included specimens of Guyanese origin
[58]. Whilst one study from Brazil did not specify whether
the individuals studied were of captive or wild origin and
were therefore not included in Fig. 2 [60], this anomaly
makes little difference to the overall picture. Similarly,
most of the African continent is data deficient, with no
BFDV studies published on wild populations north of
Zambia [61] or from any of the Indian Ocean islands other
than Mauritius. The captive studies have been slightly more
inclusive, with specimens from Cameroon and the Ivory
Coast, but they were not conducted within the country of
origin and therefore provided little information on the state
of captive flocks locally. Also, as the specimens from
captive birds originating from these nations tested positive
for BFDV [43] it would be beneficial to investigate wild
populations further for the occurrence of any spillover from
the aviculture industry.
Notably, one species that requires further research focus
is Psittacula krameri, the most introduced parrot globally
with breeding populations in approximately 35 countries
across five continents [62]. No BFDV screening has been
conducted on any of the wild populations of P. krameri
across its extensive native range in Africa and Asia.
However, feral populations within its invasive range and
captive individuals have tested positive for BFDV [30, 36,
39]. It is therefore highly likely that the virus is present in
wild flocks, which may act as a reservoir with potential
spillover into other sympatric vulnerable psittacine species.
Advances in methods
The variety of optimised diagnostic tests and technologies
available for BFDV screening have increased and
improved substantially since its first scientific assessment.
Whole-genome sequencing has become a particularly
prominent tool in recent years due to the small size of the
BFDV genome, reduced costs of this technique, and the
availability of comparable sequence data through collective
resources such as GenBank. The application of rolling-
circle amplification has greatly simplified and improved
whole-genome amplification of circoviruses for further
analysis using microarrays [63] and next-generation
sequencing techniques [64], particularly when variant
Fig. 3 Changes in the
frequency of use of the five
most common screening and
diagnostic methods used for
detecting BFDV and PBFD
between 1984 and July 2015
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sequences are present. Other methods, such as blocking
ELISAs, duplex shuttle PCRs, and dot-blot DNA
hybridization have been used once or twice but were not as
effective as other methods available or in common use at
the time. Unlike the ELISA, the HI assay, currently the
leading assay for anti-BFDV antibody detection, does not
require a secondary antibody and is widely suitable for
detection for a large proportion of psittacine species [65].
Standardisation of approaches to basic viral screening
would improve both accuracy and repeatability and allow
more reliable modelling, extrapolation and population
prevalence estimates that are comparable between coun-
tries, species or breeding facilities. These data could
facilitate research into important aspects of the epidemi-
ology of PBFD, such as pathogenesis in wild populations,
virulence and transmission. In addition, standardised
approaches and improved detection accuracy would sup-
port conservation practitioners and managers of captive
breeding facilities. For example, increased confidence in
diagnostic tests would assist decisions over the transloca-
tion of birds in species recovery and reintroduction pro-
grammes and might help to avoid the introduction of
infected individuals into disease-free captive collections.
Whilst steps have recently been taken to improve the
standard PCR protocol by quantifying DNA extraction
concentrations prior to screening [53], an assessment of
detection accuracy at variable DNA concentrations and
how this impacts the repeatability of a result is still lacking
in the literature.
Quantitative (real-time) PCR techniques are now being
more regularly applied to determine individual viral load
[37, 53, 66], as probe-based assays are able to detect viral
DNA at much lower concentrations than approaches that
rely on detection by the naked eye when visualizing a gel.
However, the reagents and equipment required for
screening using standard PCR are currently substantially
less expensive than those used for probe-based assays and
are thus likely to have continued widespread use for the
purpose of general BFDV screening.
Tissue types used for screening
Extracted DNA samples can vary greatly in yield
depending on the type and amount of tissue used. For
example, feathers typically produce very low genomic
DNA yields, particularly when extracted from those that
are cut off from the blood supply once fully grown [67],
only representing viral incidence during the initial growth
phase. Concentrations can considerably affect the sensi-
tivity of PCR assay [65], as the amount of viral DNA
obtained from any sample will be dependent on the
infection level within the host at the time of sampling [5,
68], making higher DNA yields preferable to increase the
probability of detection. A number of studies have proven
that there are inconsistencies in detection of BFDV
between tissue types [53, 65, 69, 70]. Feathers have been
found to test positive for BFDV in the absence of clinical
signs [70], in cases in which no HI antibody was detect-
able [65] and when an individual’s blood or tissue tested
negative [53].
Whilst samples from wild populations may be easier and
require less veterinary expertise to obtain through non-in-
vasive techniques, such as the collection of feathers, there
is a higher risk of cross-contamination between samples
[71] and thus may increase the proportion of false-positives
when screening. Also, as a primary symptom of PBFD is
feather loss, the collection of dropped feathers (for example
from a roost site) may further bias the estimated proportion
of infected individuals. Therefore, as with the variation in
diagnostic methods, it would be valuable to standardise a
protocol each for blood and feathers (the two most com-
monly screened tissue types) for widespread use between
managers of both wild and captive populations. As the
screening of muscle tissue and blood have been found to
provide highly comparable results with standard and qPCR
techniques [53], a standardised blood screening protocol
including host DNA quantification and an estimate of false-
negative error could therefore also be extended to use with
other internal tissues such as muscle or viscera.
Reporting of body condition
Both the body condition of screened individuals and the
techniques used to capture wild birds have been inconsis-
tently reported in the literature. As it has been shown that
some individuals can remain asymptomatic despite testing
positive for BFDV [10], it is difficult to determine whether
body condition assessments are of value in informing
management guidelines. However, overall physical condi-
tion has been found to correlate with viral load in Cape
parrots [37], and consequently, it may be of value to
implement a robust and standardised scale of clinical signs
as a primary means of assessment in the field. This finding
will need to be tested in a number of other parrot species to
determine its repeatability across the family Psittacidae
before further reliance can be placed on this as a means of
indirectly inferring host prevalence without a diagnostic
test.
Standardisation of field techniques
The under-reporting and failure to standardise techniques
used in the field limits the potential to make direct com-
parisons between studies. While efforts should be made to
standardise approaches wherever possible, it is important to
recognise that the practicalities of sampling each study
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system may limit the approaches that can be used. How-
ever, it should be taken into consideration that if a large
number of BFDV- or PBFD-positive birds are captured,
this may be due to a bias in the method of capture towards
weaker or diseased individuals. Additionally, mist nets and
traps, the most frequently used field techniques used to
catch wild birds, may facilitate the horizontal spread of
infection between individuals if equipment is not ade-
quately cleaned between uses. BFDV has been found to be
highly environmentally persistent [28], and conservation
managers should therefore be aware of the risks of
increased transmission when a thorough cleaning regime is
not implemented.
Applications
The application of screening and diagnostic tests for BFDV
has developed from trying to understand the structure of
the virus, how it is transmitted between individuals, and the
nature of the disease to assessing what incidence and
prevalence means for conservation management and
interrogating evolutionary relationships between strains.
These methodological developments have proven to be
particularly valuable when considering translocation and
reintroduction programmes for wild populations [72, 73],
highlighted by the loss of a new founder population of
endangered Psittacula echo to PBFD in 2005 [35, 74].
Initially, the virus was thought to be limited in its
diversity [75], and early attempts to produce a protective
vaccine indicated that this approach could be useful for
preventing PBFD [18, 76, 77]. Little attention has been
given to this in recent years despite it being listed as a high
priority in a threat abatement plan for PBFD in Australian
birds [56]. Instead researchers and practitioners have
focused on closer monitoring and management of infection
and disease; trying to avoid spillover into vulnerable spe-
cies [28, 40].
Our review highlights the need for greater research
focus on PBFD and BFDV in wild parrot populations,
particularly when taking into consideration the intrinsic
connection between the trade in companion birds and the
spread of novel BFDV strains into the wild [34]. Under-
standably, the application of the term ‘‘EID’’ when refer-
ring to any pathogen needs to be carefully considered in
light of its endemicity and virulence in the affected host
species. Given the number of species, subspecies and
global regions now affected by BFDV, and the recent
increase in its reported occurrence in threatened wild parrot
populations, it may now be appropriate to consider this
pathogen to be an EID. It is clear, however, that there are
still many opportunities to study the impact of infection
and disease in captive and wild parrot populations within
their countries of origin across the Americas, Africa and
Asia. Many parrot species have declining populations and
exist within highly fragmented and degraded habitats [41],
and consequently, it would be of great value in the future
conservation of wild populations to determine how the
spread of infectious disease further affects survival or
persistence. Only a few total prevalence estimates exist for
captive and wild populations. These provide valuable
information for geographical and cross-species compar-
isons that, in some cases, could be relatively easily reported
by modelling existing data on the proportion of infected
individuals or samples obtained when screening. The pro-
gression and refinement of the screening and diagnostic
tools currently available for the study of BFDV would
allow a broader application of results in management
strategies and in disease transmission prevention protocols.
The standardisation of sampling methodologies and diag-
nostic assays would be an important step towards improved
understanding of the epidemiology of PBFD and BFDV
and management of both captive and wild populations.
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